N-(dimethylaminomethylidene)-3,5-bis(trifluoromethyl)benzamide is a fluorinated intermediate typically used for the preparation of Selinexor (KPT-330), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound for the treatment of cancer disease.